The DEA ranks controlled substances from Schedule I (no accepted medical use, highest abuse potential) to Schedule V (accepted use, lowest abuse potential). Schedule II drugs like opioids and stimulants carry the strictest rules — no phone-in prescriptions, no refills — while Schedules III–V allow progressively more flexibility. Knowing a drug's schedule tells you immediately how tightly it is regulated and what to expect at the pharmacy.
DEA Drug Schedules Explained: What Schedule II, III, IV & V Mean
DISCLAIMER — This article explains federal drug scheduling for educational purposes. State laws may impose additional restrictions. Nothing here constitutes legal advice. Possession of controlled substances without a valid prescription is a federal crime.
If you've ever picked up a prescription and noticed a "CII" label on the pharmacy bag, or wondered why your doctor can call in a refill for some medications but has to write a separate paper prescription for others, the answer lies in the DEA's controlled substance scheduling system. Understanding how schedules work — and what each one means in practice — helps you understand your own medications, navigate the pharmacy system more confidently, and recognize why certain rules exist around specific drugs.
The Legal Foundation: The Controlled Substances Act of 1970
The framework for scheduling drugs in the United States was established by the Controlled Substances Act (CSA) of 1970, signed into law by President Nixon as part of the broader Comprehensive Drug Abuse Prevention and Control Act. The CSA consolidated dozens of federal drug laws into a single statute and created the five-schedule classification system still in use today.
Administration falls primarily to the Drug Enforcement Administration (DEA), which operates under the Department of Justice. The Food and Drug Administration (FDA) also plays a role: scheduling decisions require FDA input on a drug's medical utility and abuse potential, and the two agencies often must agree before rescheduling can occur. Either the DEA itself, HHS (through the FDA), or any interested party (including drug manufacturers and advocacy organizations) can petition for scheduling or rescheduling.
The two central criteria that determine a drug's schedule are: (1) its potential for abuse and dependence, and (2) whether it has a currently accepted medical use in the United States. These two axes — abuse potential and medical utility — define the schedule boundaries.
The Five Schedules
Schedule I is reserved for substances the DEA and FDA have determined have no currently accepted medical use in the United States and a high potential for abuse. Because they have no accepted medical use, they cannot be legally prescribed. Researchers can study them only under highly restricted DEA registration.
Examples include heroin, LSD, MDMA (ecstasy), psilocybin (the active compound in psychedelic mushrooms), and marijuana at the federal level. The last item is important to note: marijuana remains a Schedule I controlled substance federally as of this writing, despite being legal for medical or recreational use in the majority of U.S. states. The DEA proposed rescheduling marijuana to Schedule III in 2024, a process that remained ongoing as of mid-2026. Until any rescheduling is finalized, federal law treats marijuana as Schedule I.
Schedule II drugs have accepted medical uses but carry the highest recognized potential for physical and psychological dependence of any prescribable substance. The regulations around them are the most stringent in ambulatory medicine.
The opioid family dominates this schedule: oxycodone (OxyContin, Percocet), hydrocodone combinations (Norco, previously Schedule III), fentanyl (Duragesic), morphine, methadone, and hydromorphone (Dilaudid) are all Schedule II. Stimulants are also heavily represented: amphetamine salts (Adderall), mixed amphetamine salts (Vyvanse), and methylphenidate (Ritalin, Concerta) are Schedule II. Cocaine — still used as a topical anesthetic in ENT surgery — is Schedule II. Methamphetamine, in a specific prescription form (Desoxyn), is Schedule II for obesity and ADHD treatment.
Why Schedule II means no refills: A Schedule II prescription expires the moment it is filled. To get more, the patient must obtain a new prescription — in most states, either in writing or through a state-certified electronic prescribing system. The prescriber cannot simply call the pharmacy to authorize more, and the pharmacy cannot dispense early. This is why managing a Schedule II medication feels more logistically demanding than other prescriptions.
Schedule III drugs have accepted medical uses and a lower potential for abuse than Schedule I or II substances, though their misuse can lead to moderate to low physical dependence or high psychological dependence. Prescriptions can be refilled, and phone or electronic call-in prescriptions are generally permitted.
Buprenorphine (Suboxone, Belbuca), used for opioid use disorder treatment and chronic pain, is Schedule III — though its prescribing has historically required additional DEA certification (the X-waiver), which was eliminated in 2023 to increase access. Ketamine (Ketalar) — increasingly used for treatment-resistant depression — is Schedule III. Anabolic steroids (testosterone formulations, nandrolone) are Schedule III. Combination codeine products with limited codeine content (Tylenol with Codeine No. 3 in most states) fall into Schedule III, though some states classify them more restrictively.
Schedule IV is where most benzodiazepines and several sleep aids live — a category of drugs that are extremely widely prescribed yet carry meaningful dependence risk, which is sometimes underappreciated by patients who assume their anxiety medication isn't "a controlled substance."
The benzodiazepine family is almost entirely Schedule IV: alprazolam (Xanax), diazepam (Valium), clonazepam (Klonopin), lorazepam (Ativan), and temazepam (Restoril) are all here. Z-drugs — the non-benzodiazepine sleep medications zolpidem (Ambien), zaleplon (Sonata), and eszopiclone (Lunesta) — are Schedule IV. Tramadol, the opioid-serotonin reuptake inhibitor discussed in our serotonin syndrome article, is Schedule IV federally (though some states, recognizing its high diversion and misuse rates, treat it as Schedule II locally). Phentermine, used for short-term obesity management, is Schedule IV.
Schedule V drugs have the lowest potential for abuse and dependence among controlled substances, and some are available without a prescription in limited quantities in certain states (the pharmacist logs the purchaser). These are typically preparations containing small amounts of traditionally controlled substances.
Pregabalin (Lyrica), used for nerve pain, fibromyalgia, and seizures, is Schedule V. Lacosamide (Vimpat), an anticonvulsant, is Schedule V. Low-dose codeine cough syrups (less than 200 mg of codeine per 100 mL — like certain Robitussin formulations) are Schedule V and available OTC in some states. Ezogabine (Potiga), now discontinued, was Schedule V.
Real-World Implications for Patients
Prescription Drug Monitoring Programs (PDMPs)
Every state now operates a Prescription Drug Monitoring Program — a state-run electronic database that records every controlled substance prescription dispensed. When you fill a controlled substance at any pharmacy, that transaction is logged in the PDMP. Prescribers and pharmacists check the PDMP before prescribing or dispensing controlled substances to identify patients who may be receiving overlapping prescriptions from multiple providers (doctor shopping) or pharmacies. In many states, checking the PDMP is now mandatory before writing Schedule II prescriptions.
Early Refill Restrictions
Even within the allowed refill windows, pharmacies and insurance plans commonly apply "too soon" rules — refusing to fill a prescription before a certain percentage of the previous supply has been used. For Schedule II medications, this is moot since no refills are allowed, but for Schedule III and IV drugs, patients who run out early (lost medication, travel plans, dose changes) may find themselves unable to fill a new prescription without prior authorization or a visit to their prescriber.
Notable Reschedulings and Changes
Drug scheduling is not static. In October 2014, the DEA moved hydrocodone combination products (including the M365 pill described in our companion article) from Schedule III to Schedule II — a significant change that affected millions of patients who had to shift from call-in refillable prescriptions to the far more restrictive Schedule II process. The marijuana proposed rescheduling to Schedule III, if finalized, would be one of the most consequential rescheduling events in the CSA's history. Pregabalin was added to Schedule V in 2005 after initial concerns it would be placed higher.
State Law Variations
Federal scheduling sets a floor, not a ceiling. States can — and many do — impose stricter controls than federal law requires. Some states classify tramadol as Schedule II (stricter than the federal Schedule IV). Several states have placed gabapentin (Neurontin) on their state controlled substance lists even though it remains unscheduled federally. Carisoprodol (Soma) is a Schedule IV substance federally but has been placed on more restrictive schedules in several states due to diversion concerns. If you receive a prescription while traveling or move to a new state, the rules around your medication may be different than what you're used to.
Practical tip: If you're traveling domestically with Schedule II medications, carry the original pharmacy-labeled bottle and, ideally, a copy of your prescription. While federal law doesn't require this, it protects you if your medication is ever questioned by law enforcement. Traveling internationally with controlled substances requires research into the destination country's specific laws — many countries classify drugs differently from the U.S., and some have zero-tolerance policies for substances that are prescription-legal here.
Frequently Asked Questions
What does a DEA drug schedule mean?
DEA scheduling is a classification system created by the Controlled Substances Act that categorizes drugs by their medical usefulness and potential for abuse or dependence. Schedule I drugs are considered to have no accepted medical use and high abuse potential (heroin, LSD). Schedules II through V have accepted medical uses, with Schedule II having the highest abuse potential of those (oxycodone, amphetamine) and Schedule V the lowest (some cough preparations). The schedule determines prescribing rules, refill restrictions, and penalties for illegal possession.
What is the difference between Schedule II and Schedule IV controlled substances?
Schedule II substances (oxycodone, fentanyl, amphetamine, methamphetamine) have the highest abuse potential among drugs with accepted medical uses — they require a new written prescription for every fill, cannot be called in by phone in most circumstances, and carry no refills. Schedule IV substances (benzodiazepines, tramadol, zolpidem) have a lower recognized abuse potential and allow prescriptions to be phoned in, faxed, or electronically submitted in most states, with up to five refills permitted in a 180-day period.
Can I get a refill on a Schedule II prescription?
No. Federal law prohibits refills on Schedule II controlled substance prescriptions — a new, valid prescription is required for every dispensing. Some states allow prescribers to issue multiple prescriptions for Schedule II substances at a single visit (with instructions not to fill until a certain date), but each fill still requires a separate, valid prescription document. This is a major practical difference between Schedule II and lower schedules.
Is marijuana a controlled substance under federal law?
Yes. Under federal law, marijuana (cannabis) remains a Schedule I controlled substance — meaning the DEA considers it to have no currently accepted medical use and a high potential for abuse. This federal classification persists regardless of state-level legalization or medical use laws. As of 2024, the DEA proposed rescheduling cannabis to Schedule III, but this process was still ongoing. The federal-state conflict creates legal complexities, particularly around banking, interstate commerce, and federal employment drug testing.
Identify an unknown pill and see its DEA schedule instantly
Browse Controlled Substances →